A head-to-head comparison of two popular lipid-lowering medications suggests that rosuvastatin may be a better option than atorvastatin when it comes to decreasing the risk of all-cause mortality and ...
Among those with CAD, both rosuvastatin and atorvastatin are similarly effective regarding the combination of all-cause death, MI, stroke, or any coronary revascularization over 3 years, according to ...
There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29 in Annals of Internal Medicine ...
Two widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease. But while rosuvastatin treatment is ...
In a head-to-head test of two popular cholesterol-lowering statin drugs — Lipitor and Crestor — both medications worked equally well.more Lipitor (atorvastatin) and Crestor (rosuvastatin) both ...
Two widely used statins, rosuvastatin and atorvastatin, are equally effective at preventing heart attacks, strokes and death in people with coronary artery disease. But while rosuvastatin treatment is ...
Please provide your email address to receive an email when new articles are posted on . Compared with atorvastatin, rosuvastatin is associated with increased risks of hematuria, proteinuria and kidney ...
Kyoto, Japan, Monday 29 September 2003. New data presented at the XIIIth International Symposium on Atherosclerosis (ISA) show AstraZeneca's highly effective statin CRESTOR (rosuvastatin) achieves ...
Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile ...
Objective: The study compared low-density lipoprotein cholesterol (LDL-C) reduction obtained after switching patients on a statin therapy to rosuvastatin or simvastatin in real-world clinical practice ...
Millions of older adults already take cholesterol-lowering statins for heart health, and a growing body of observational ...